These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 17561543

  • 1. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 15; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 3. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia.
    Marrs JC.
    Ann Pharmacother; 2008 Jul 15; 42(7):1070-9. PubMed ID: 18594049
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 15; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 5. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep 15; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 15; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 7. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun 15; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 8. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 9. Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia.
    Lankford A, Ancoli-Israel S.
    Int J Clin Pract; 2007 Jun 15; 61(6):1037-45. PubMed ID: 17386060
    [Abstract] [Full Text] [Related]

  • 10. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK, Salkeld L, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2010 Jan 15; 11(1):23-30. PubMed ID: 19945340
    [Abstract] [Full Text] [Related]

  • 11. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep 15; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

  • 12. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH, Burke PJ.
    Curr Med Res Opin; 2008 Mar 15; 24(3):837-46. PubMed ID: 18257978
    [Abstract] [Full Text] [Related]

  • 13. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul 15; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 14. Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.
    Scharf MB, Black J, Hull S, Landin R, Farber R.
    Sleep; 2007 Jun 15; 30(6):743-52. PubMed ID: 17580596
    [Abstract] [Full Text] [Related]

  • 15. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 15; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 17. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 18. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug 15; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.
    Roth T, Zammit GK, Scharf MB, Farber R.
    Sleep; 2007 Dec 15; 30(12):1731-8. PubMed ID: 18246982
    [Abstract] [Full Text] [Related]

  • 20. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr 15; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.